These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Delayed-type hypersensitivity, in vitro T-cell responsiveness and risk of active coccidioidomycosis among HIV-infected patients living in the coccidioidal endemic area. Ampel NM Med Mycol; 1999 Aug; 37(4):245-50. PubMed ID: 10421859 [TBL] [Abstract][Full Text] [Related]
27. Biochemical characterization of an in-house Coccidioides antigen: perspectives for the immunodiagnosis of coccidioidomycosis. Filho RE; Bandeira SP; Brillhante RS; Rocha MF; Vasconcelos IM; Pereira ML; Castelo-Branco Dde S; Rocha FA; Camargo ZP; Ramos MV; Cordeiro Rde A; Sidrim JJ Molecules; 2012 Jun; 17(7):7854-63. PubMed ID: 22743589 [TBL] [Abstract][Full Text] [Related]
28. Comparisons of mycelia- and spherule-derived antigens in cellular immune assays of Coccidioides immitis-infected guinea pigs. Cox RA; Mead CG; Pavey EF Infect Immun; 1981 Feb; 31(2):687-92. PubMed ID: 7012017 [TBL] [Abstract][Full Text] [Related]
30. In vitro studies with "transfer factor": transfer of the cell-migration inhibition correlate of delayed hypersensitivity in humans with cell lysates from humans sensitized to histoplasmin, coccidioidin, or PPD. Paque RE; Kniskern PJ; Dray S; Baram P J Immunol; 1969 Nov; 103(5):1014-21. PubMed ID: 5350964 [No Abstract] [Full Text] [Related]
32. Delayed-type hypersensitivity responses to a cell wall fraction of the mycelial phase of Coccidioides immitis. Ward ER; Cox RA; Schmitt JA; Huppert M; Sun SH Infect Immun; 1975 Nov; 12(5):1093-7. PubMed ID: 1193725 [TBL] [Abstract][Full Text] [Related]
33. [Cutaneous sensitivity to C. immitis. Comparison between the spherulin and coccidiodin reaction in man]. Levine HB; Gonzălez Ochoa A; Ten Eyck DR Bol Oficina Sanit Panam; 1973 Mar; 74(3):199-207. PubMed ID: 4266786 [No Abstract] [Full Text] [Related]
34. [Transfer of delayed type hypersensitivity in guinea pigs]. Smogorzewska E Probl Med Wieku Rozwoj; 1990; 16():167-88. PubMed ID: 2152405 [TBL] [Abstract][Full Text] [Related]
35. Experimental coccidioidomycosis: effects of cyclophosphamide in immunologic responses. Rubinstein HR; Masih DT; Marticorena B; Riera CM Mycopathologia; 1986 May; 94(2):91-5. PubMed ID: 3724838 [TBL] [Abstract][Full Text] [Related]
36. Induction of tolerance to coccidioidin in newborn guinea pigs. Ibrahim AB J Immunol; 1974 Jan; 112(1):387-91. PubMed ID: 4812177 [No Abstract] [Full Text] [Related]
37. Spherulin as a complement-fixing antigen in human coccidioidomycosis. Scalarone GM; Levine HB; Pappagianis D; Chaparas SD Am Rev Respir Dis; 1974 Sep; 110(3):324-8. PubMed ID: 4213393 [No Abstract] [Full Text] [Related]
38. Development of vaccines for coccidioidomycosis. Levine HB; Pappagianis D; Cobb JM Mycopathol Mycol Appl; 1970; 41(1):177-85. PubMed ID: 4999877 [No Abstract] [Full Text] [Related]
39. Mechanism of RNA-mediated transfer of cellular immunity. Mannick JA; Deckers PJ Ann N Y Acad Sci; 1973 May; 207():398-405. PubMed ID: 4126328 [No Abstract] [Full Text] [Related]
40. Monkey to human transfer of delayed hypersensitivity in vitro with RNA extracts. Paque RE; Dray S Cell Immunol; 1972 Sep; 5(1):30-41. PubMed ID: 4626841 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]